Patent details

Basic Information

Publication number:

EP2641601

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP131683831

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Methods of treating multiple myeloma using combination therapies based on HuLuc63 with bortezomib

French Title of Invention:

Procédés de traitement du myélome multiple à l'aide de polythérapies à base de HuLuc63 et bortezomib

German Title of Invention:

Verfahren zur Behandlung von Multiplem-Myelomen mit hilfe von Kombinationstherapien auf Basis von HuLuc63 und Bortezomib

SPC Number:

Dates

Filing date:

07/08/2007

Grant date:

06/07/2016

EP Publication Date:

06/07/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/09/2013

EP B1 Publication Date:

06/07/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

07/08/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/07/2016

 

 

Name:

AbbVie Biotherapeutics Inc.

Address:

1500 Seaport Boulevard, Redwood City, CA 94063, United States (US)

Name:

Dana-Farber Cancer Institute Inc.

Address:

450 Brookline Avenue, Boston, MA 02215, United States (US)

Agent

Name:

VALIPAT

From:

11/08/2016

Address:

Uitbreidingstraat 72-5, 2600, Antwerp, Belgium (BE)

To:

Inventor

1

Name:

Tai Yu-Tzu

Address:

United States (US)

2

Name:

Andersen Kenneth C.

Address:

United States (US)

3

Name:

Afar Daniel

Address:

United States (US)

Priority

1

Priority Number:

836185 P

Priority Date:

07/08/2006

Priority Country:

United States (US)

2

Priority Number:

944262 P

Priority Date:

15/06/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/573;

Annual Fees

Annual Fee Due Date:

01/09/2025

Annual Fee Number:

19

Annual Fee Amount:

281 Euro

Expected Payer:

Last Annual Fee Payment Date:

11/07/2024

Last Annual Fee Paid Number:

18

Last Annual Fee Paid Amount:

262 Euro

Payer:

MASTER DATA CENTER INC (ex Clarivate Analytics)

Filing date	Document type	Number of pages